Resolution of corticosteroid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach

J Asthma. 2009 Jun;46(5):445-7. doi: 10.1080/02770900902849871.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Aspergillosis, Allergic Bronchopulmonary / complications
  • Aspergillosis, Allergic Bronchopulmonary / drug therapy*
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / drug therapy
  • Diabetes Mellitus / chemically induced*
  • Glucocorticoids / adverse effects*
  • Humans
  • Hyperglycemia / chemically induced
  • Male
  • Omalizumab

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Omalizumab